What are the Breast Imaging Reporting and Data System (BIRADS) categories and the recommended management for each?

BI-RADS Classification System and Management

The Breast Imaging Reporting and Data System (BI-RADS) is a standardized 7-category classification (0-6) that directly links imaging findings to specific management recommendations, with categories 1-2 returning to routine screening, category 3 requiring short-interval follow-up, categories 4-5 mandating tissue biopsy, and category 6 indicating known malignancy requiring definitive treatment. 1

BI-RADS Categories and Recommended Management

Category 0: Incomplete Assessment

• Definition: Needs additional imaging evaluation and/or prior mammograms for comparison
• Management: Obtain additional imaging (spot compression, magnification views, ultrasound) or prior studies for comparison 2
• Context: Almost always used in screening situations when a finding requires further workup

Category 1: Negative

• Definition: Completely normal mammogram with symmetric breasts, no masses, architectural distortion, or suspicious calcifications
• Management: Resume routine annual screening mammography 2, 1
• Malignancy risk: 0%

Category 2: Benign Findings

• Definition: Negative mammogram with identifiable benign findings (calcifying fibroadenoma, oil cyst, lipoma, intramammary lymph nodes, vascular calcification, implants, or post-surgical architectural distortion)
• Management: Resume routine annual screening mammography 2, 1
• Malignancy risk: 0%

Category 3: Probably Benign

• Definition: Findings that are usually benign with <2% malignancy risk
• Management:
  • Diagnostic mammogram at 6 months
  • Then every 6-12 months for 1-2 years 1
  • If stable or resolved: return to routine screening
  • If increased size or changing characteristics: proceed to biopsy
• Exceptions requiring immediate biopsy:
  • Uncertain patient follow-up compliance
  • Patient strongly desires biopsy
  • Strong family history of breast cancer 1

Category 4: Suspicious Abnormality

• Definition: Lesions with variable malignancy probability (higher than category 3, lower than category 5) that are not obviously malignant
• Management: Tissue diagnosis required 1
  • Preferred: Core needle biopsy
  • Alternative: Needle localization excisional biopsy with specimen radiograph
• Critical requirement: Pathology-imaging concordance must be verified
  • If discordant: repeat imaging and/or additional tissue sampling
  • If persistently discordant: surgical excision mandatory 1
• If benign with concordance: Follow-up mammography every 6-12 months for 1-2 years before returning to routine screening 1

Category 5: Highly Suggestive of Malignancy

• Definition: ≥95% probability of cancer (spiculated mass, malignant-appearing pleomorphic calcifications)
• Management: Tissue diagnosis required 2
  • Preferred: Core needle biopsy
  • Alternative: Needle localization excisional biopsy with specimen radiograph
• Critical requirement: Pathology-imaging concordance must be verified
  • Benign pathology with category 5 imaging is clearly discordant and unacceptable
  • Surgical excision recommended when pathology and imaging remain discordant 1

Category 6: Known Biopsy-Proven Malignancy

• Definition: Breast lesions confirmed malignant through biopsy but before definitive therapy
• Management: Manage according to breast cancer treatment guidelines 2, 1
• Note: This category was added in the 4th edition of BI-RADS 2

Important Clinical Considerations

Multi-Modality Imaging

When multiple imaging modalities are performed (mammography + ultrasound), the final BI-RADS category represents cumulative findings and is based on the most worrisome finding present 2. The category can change (increase, decrease, or remain the same) after additional imaging 2.

Common Pitfalls to Avoid

1. Category 3 misuse: Do not use category 3 for initial screening findings without diagnostic workup. Category 0 should be assigned first, then category 3 only after complete diagnostic evaluation 2

2. Inadequate follow-up for category 4/5: Never substitute imaging follow-up for tissue diagnosis in categories 4 and 5 1

3. Ignoring pathology-imaging discordance: A benign core biopsy result does not exclude malignancy if imaging remains highly suspicious. Surgical excision is mandatory when discordance persists 1

4. Premature return to screening after benign biopsy: Even with concordant benign pathology in category 4 lesions, continue surveillance mammography every 6-12 months for 1-2 years before resuming routine screening 1